SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011908
Filing Date
2021-05-13
Accepted
2021-05-13 07:14:36
Documents
49
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20210331_10q.htm 10-Q 598095
2 EXHIBIT 10.1 ex_249212.htm EX-10.1 157011
3 EXHIBIT 31.1 ex_239625.htm EX-31.1 15709
4 EXHIBIT 31.2 ex_239626.htm EX-31.2 15393
5 EXHIBIT 32.1 ex_239627.htm EX-32.1 8393
12 img01.jpg GRAPHIC 771
  Complete submission text file 0001437749-21-011908.txt   3295766

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wint-20210331.xml EX-101.INS 489314
7 XBRL TAXONOMY EXTENSION SCHEMA wint-20210331.xsd EX-101.SCH 39369
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20210331_cal.xml EX-101.CAL 24578
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20210331_def.xml EX-101.DEF 276552
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20210331_lab.xml EX-101.LAB 242995
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20210331_pre.xml EX-101.PRE 286702
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 21917170
SIC: 2836 Biological Products, (No Diagnostic Substances)